-
公开(公告)号:EP3524958B1
公开(公告)日:2024-09-25
申请号:EP18211011.4
申请日:2008-11-25
CPC分类号: G01N33/82 , Y10T436/20 , Y10T436/203332 , Y10T436/24 , Y10T436/10
-
公开(公告)号:EP3411011B1
公开(公告)日:2024-09-18
申请号:EP17748282.5
申请日:2017-02-03
IPC分类号: A61K8/60 , A61K8/36 , A61K8/67 , A61Q17/00 , A61Q19/00 , A61Q19/08 , A61K8/99 , A61K31/714 , A61K35/74 , C12Q1/04 , G01N33/82 , A61P17/10
CPC分类号: A61Q19/00 , A61K8/606 , A61Q19/08 , A61K8/99 , A61K31/714 , C12Q1/04 , G01N33/82 , A61K2800/8120130101 , G01N2800/2020130101 , A61K35/74 , A61P17/10
-
公开(公告)号:EP4414709A1
公开(公告)日:2024-08-14
申请号:EP22878706.5
申请日:2022-08-11
发明人: KIM, Seung Ku , KIM, Ki Tae
IPC分类号: G01N33/574 , G01N33/82 , G01N33/92 , G01N33/68 , G01N30/72
CPC分类号: G01N33/92 , G01N33/82 , G01N30/72 , G01N33/68 , G01N33/574
摘要: The present invention relates to biomarkers for cancer diagnosis and uses thereof, and more particularly to a composition for diagnosing or predicting cancer prognosis, comprising an agent for measuring levels of at least two biomarkers selected from the group consisting of Complement Component 7 (C7), Dodecanoyl-L-carnitine (DC), Lysophosphatidylcholine (LPC), Histidine-Rich Glycoprotein (HRG) and Osteopontin in blood, and a method of using the biomarker to provide information about the diagnosis or prognosis of cancer.
In the present invention, it was confirmed that the level of complement component 7 (C7), dodecanoyl-L-carnitine (DC), lysophosphatidylcholine (LPC), histidine-rich glycoprotein (HRG), and/or osteopontin (OPN) in blood of lung and/or hepatic cancer patients has been found to have different patterns than that of normal individuals, and the combination of these markers has been shown to improve the diagnosis of various cancers, including lung or hepatic cancer. Accordingly, the biomarkers of the present invention can be useful in cancer diagnosis and prognosis.-
公开(公告)号:EP4379384A2
公开(公告)日:2024-06-05
申请号:EP24164757.7
申请日:2020-01-15
IPC分类号: G01N33/82
CPC分类号: B01L3/502761 , B01L2200/1620130101 , B01L2300/08720130101 , B01L3/502715 , C12Q1/44 , G01N33/92 , G01N33/82 , G01N33/743 , G01N2333/9220130101 , G01N33/54393
摘要: Methods of mitigating lipoprotein interference in in vitro diagnostic assays for target hydrophobic analytes are disclosed, as well as compositions, kits, and devices useful in said methods. A pretreatment reagent is utilized that includes at least one enzyme that digests lipoprotein.
-
公开(公告)号:EP3645998B1
公开(公告)日:2023-11-15
申请号:EP18823246.6
申请日:2018-06-26
发明人: Mendoza, Estevan
IPC分类号: G01N1/28 , G01N33/483 , G01N33/487 , G01N33/49 , G01N33/50 , G01N33/53 , G01N33/82 , G01N33/98 , G01N35/00 , G01N37/00 , B01L3/00 , G01N1/40 , G01N33/543 , G01N33/558 , G01N35/10
-
公开(公告)号:EP3152185B1
公开(公告)日:2023-10-04
申请号:EP15725061.4
申请日:2015-06-01
发明人: KOBOLD, Uwe , THIELE, Roland , WEISS, Noah , BROWN, Lauren
IPC分类号: G01N27/623 , G01N33/82 , G01N33/487
-
-
公开(公告)号:EP3359200B1
公开(公告)日:2023-08-02
申请号:EP16854239.7
申请日:2016-10-05
发明人: BORRELLI, Joseph , TANG, Liping , ZHOU, Jun
-
公开(公告)号:EP3401681B1
公开(公告)日:2023-03-29
申请号:EP18168500.9
申请日:2018-04-20
发明人: CHOI, Euiyul , JOO, Hoodon , KIM, Jinsu
IPC分类号: G01N33/558 , G01N33/68 , G01N33/82
-
10.
公开(公告)号:EP3973290A1
公开(公告)日:2022-03-30
申请号:EP20730516.0
申请日:2020-05-14
申请人: ProciseDx Inc.
发明人: ZHOU, Jinyao , HALE, Michael , WESTIN, Stefan , RENSHAW, Mark , MIMMS, Larry , REDDY, Rukmini , SRIKRISHNAN, Raj
IPC分类号: G01N33/542 , G01N33/82
-
-
-
-
-
-
-
-
-